Dusseldorf - Delayed Quote EUR

Ultragenyx Pharmaceutical Inc (UP0.DU)

37.60 -1.40 (-3.59%)
At close: June 7 at 7:30 PM GMT+2

Key Executives

Ultragenyx Pharmaceutical Inc

Description

Corporate Governance

Ultragenyx Pharmaceutical Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 1, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

Ultragenyx Pharmaceutical Inc Earnings Date

Recent Events

April 17, 2024 at 12:00 PM UTC

To to discuss new data from GTX-102 Phase 1/2 clinical study

March 13, 2024 at 1:00 PM UTC

at Barclays Global Healthcare Conference

March 12, 2024 at 10:59 AM UTC

at Leerink Partners Global Biopharma Conference

February 15, 2024 at 10:00 PM UTC

Q4 2023 Earnings Call

Related Tickers

RYIS.MU Viracta Therapeutics Inc
12.53
+250.00%
 
TF2.DU Takara Bio Inc
5.60
+0.90%
 
RXK2.SG SELLAS Life Sciences Group Inc
0.1100
0.00%
 
V6M.F Relief Therapeutics Holding AG
3.5325
0.00%
 
VACBF Nykode Therapeutics AS
1.5000
0.00%
 
XOMAP XOMA Corporation
25.00
-1.29%
 
ALMDP.PA Medesis Pharma S.A.
0.9920
+1.22%
 
HAVLF HAVN Life Sciences Inc.
0.0274
0.00%
 
STAB Statera Biopharma, Inc.
0.0006
0.00%
 
VAL.L ValiRx plc
2.8500
+3.64%